Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physicians
Background With the approval of biosimilars for subcutaneously administered products, such as adalimumab, etanercept and insulin, biosimilars become increasingly available in ambulatory care. Little is known about the knowledge and attitudes of healthcare providers who are in charge of dispensing an...
Saved in:
Main Authors: | Liese Barbier (Author), Yannick Vandenplas (Author), Steven Simoens (Author), Paul Declerck (Author), Arnold G. Vulto (Author), Isabelle Huys (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
by: Yannick Vandenplas, et al.
Published: (2022) -
Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking
by: Liese Barbier, et al.
Published: (2022) -
Informing Patients about Biosimilar Medicines: The Role of European Patient Associations
by: Yannick Vandenplas, et al.
Published: (2021) -
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
by: Yannick Vandenplas, et al.
Published: (2021) -
Off-Patent Biologicals and Biosimilars Tendering in Europe-A Proposal towards More Sustainable Practices
by: Liese Barbier, et al.
Published: (2021)